Artal Group S.A. - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 120 filers reported holding KRYSTAL BIOTECH INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q2 2023$41,051
+24.4%
349,669
-15.1%
1.27%
-35.1%
Q1 2023$32,991
+4.1%
412,082
+3.0%
1.96%
+10.8%
Q4 2022$31,688
-99.9%
400,000
-20.0%
1.77%
+19.0%
Q3 2022$34,850,000
+6.2%
500,0000.0%1.49%
-15.2%
Q2 2022$32,830,000
-1.3%
500,0000.0%1.75%
+25.8%
Q1 2022$33,270,000
-32.1%
500,000
-28.6%
1.39%
+4.8%
Q4 2021$48,965,000
+87.6%
700,000
+40.0%
1.33%
+127.6%
Q3 2021$26,105,000
-23.2%
500,0000.0%0.58%
-15.4%
Q2 2021$34,000,000
-11.7%
500,0000.0%0.69%
+1.3%
Q1 2021$38,520,000
+170.3%
500,000
+110.5%
0.68%
+122.5%
Q4 2020$14,250,000
+39.4%
237,5000.0%0.31%
+23.4%
Q3 2020$10,224,000
+23.4%
237,500
+18.8%
0.25%
+6.9%
Q2 2020$8,284,000
+91.6%
200,000
+100.0%
0.23%
+26.8%
Q1 2020$4,324,000
-2.4%
100,000
+25.0%
0.18%
+7.0%
Q4 2019$4,430,000
-15.0%
80,000
-46.7%
0.17%
-18.2%
Q3 2019$5,209,000
-56.9%
150,000
-50.0%
0.21%
-57.3%
Q2 2019$12,081,000
+22.4%
300,0000.0%0.49%
+21.3%
Q1 2019$9,870,000
+72.7%
300,000
+9.1%
0.40%
+90.1%
Q4 2018$5,715,000
+116.7%
275,000
+83.3%
0.21%
+207.2%
Q3 2018$2,637,000
+18.2%
150,0000.0%0.07%
+46.8%
Q2 2018$2,231,000
+47.4%
150,0000.0%0.05%
+147.4%
Q1 2018$1,514,000
-4.1%
150,0000.0%0.02%
-20.8%
Q4 2017$1,578,000
+58.3%
150,000
+50.0%
0.02%
+41.2%
Q3 2017$997,000100,0000.02%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q2 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 771,250$53,949,0004.15%
First Light Asset Management, LLC 680,170$47,578,0003.41%
ACT CAPITAL MANAGEMENT, LLC 59,000$4,127,0002.98%
S Squared Technology, LLC 95,215$6,660,0002.98%
Redmile Group, LLC 1,820,898$127,372,0002.90%
Soleus Capital Management, L.P. 228,437$15,979,0001.60%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 50,922$3,562,0001.59%
Artal Group S.A. 700,000$48,965,0001.33%
SILVERARC CAPITAL MANAGEMENT, LLC 46,670$3,265,0001.32%
Kynam Capital Management, LP 34,816$2,435,0001.30%
View complete list of KRYSTAL BIOTECH INC shareholders